ArticleMaterials today. Bio2022

ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment.

Chen Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.